NCT02792387View on ClinicalTrials.gov

The Role of CVP and EF in Patients With Cardio-renal Syndromes

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

May 31, 2016

Study Completion Date

January 31, 2017

Conditions
Heart Failure
Interventions
OTHER

CVP measurement

CVP measurements had been performed with an electronic pressure transducer in spontaneously breathing non-ventilated patients. Central vein access was established trough the subclavian or internal jugular veins. Mean CVP was recorded for each patient, measured in mmHg.

All Listed Sponsors
lead

Tbilisi State University

OTHER

NCT02792387 - The Role of CVP and EF in Patients With Cardio-renal Syndromes | Biotech Hunter | Biotech Hunter